-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MQbOfNmxYA42kFZ18ySFhOtgpFopy7OCcUL8okDaMrJ/XMzBy3uyk2msy7wAMFJX BeDA31ZzZc16wpDQgPHeBQ== 0001193125-09-142766.txt : 20090701 0001193125-09-142766.hdr.sgml : 20090701 20090701160144 ACCESSION NUMBER: 0001193125-09-142766 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090630 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090701 DATE AS OF CHANGE: 20090701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 09922595 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 30, 2009

 

 

ALEXION PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-27756   13-3648318

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

352 Knotter Drive, Cheshire, Connecticut 06410

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (203) 272-2596

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01 Entry Into a Material Definitive Agreement.

On June 30, 2009, Alexion Manufacturing LLC, or Alexion Manufacturing, a wholly-owned subsidiary of the registrant Alexion Pharmaceuticals, Inc., or Alexion, amended its mortgage loan agreement with iStar Tara LLC (successor in interest to iStar Financial Inc.) to permit the prepayment of the mortgage loan without penalty. The original terms of the mortgage loan permitted prepayment at any time after July 11, 2009 and each prepayment would be subject to a prepayment penalty. As of June 30, 2009, the aggregate principal amount of the mortgage loan was $44,000,000.

The amendment to the mortgage loan permits prepayment at any time after June 30, 2009 and without penalty if prepaid prior to January 5, 2010, provided no event of default exists. As described in the amendment, Alexion expects to prepay $5,000,000 in principal on the first business day of each month, commencing July 1, 2009 through December 1, 2009, and make a final payment of $14,000,000 on or prior to January 5, 2010. Alexion may prepay the entire mortgage loan at any time prior to January 5, 2010 without penalty. If Alexion does not prepay the entire principal balance on or prior to January 5, 2010, any prepayment made after such date must be accompanied by the prepayment penalty set forth in the mortgage loan agreement.

The other material terms and conditions of the original loan remain in force and effect as described in Alexion’s filings with the U.S. Securities and Exchange Commission.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The disclosure provided in Item 1.01 “Entry Into a Material Definitive Agreement” is incorporated by reference into this Item 2.03 as if fully set forth herein.

 

Item 9.01 Financial Statements and Exhibits

 

  (d) Exhibits

 

  10.1 Amendment to Loan and Security Agreement dated as of July 11, 2006, by and between Alexion Manufacturing LLC, as borrower, Alexion Pharmaceuticals, Inc., as guarantor, and iStar Tara LLC, as lender

 

2


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ALEXION PHARMACEUTICALS, INC.
Date: July 1, 2009   By:  

/s/    Thomas I.H. Dubin

  Name:   Thomas I.H. Dubin
  Title:   Senior Vice President and General Counsel

 

3

EX-10.1 2 dex101.htm AMENDMENT TO LOAN AND SECURITY AGREEMENT Amendment to Loan and Security Agreement

Exhibit 10.1

As of June 30, 2009

iStar Tara LLC

c/o iStar Financial Inc.

1114 Avenue of the Americas

New York, New York 10036

 

Re: Amendment to the Loan and Security Agreement dated as of July 11, 2006

To Whom It May Concern:

This letter agreement (this “Amendment”) sets forth the agreement of Alexion Manufacturing LLC, a Delaware limited liability company (“Borrower”) on the one hand, and iStar Financial Inc., a Maryland corporation (the “Initial Lender”) on the other hand, with regard to certain matters pertaining to the prepayment provisions of the Loan Agreement (hereafter defined). On July 11, 2006, Borrower and Initial Lender executed (i) that certain Loan and Security Agreement (as amended from time to time, collectively, the “Original Loan Agreement”) pursuant to which Initial Lender made a loan to Borrower in the aggregate principal amount of up to Twenty Six Million and 00/100 dollars ($26,000,000) (the “Initial Loan”); (ii) that certain Promissory Note, dated the same, in the principal amount of Twenty Six Million and 00/100 dollars ($26,000,000) (the “Original Note”); and (iii) the other Loan Documents each dated as of July 11, 2006. Subsequently, the above referenced documents were amended by that certain First Amendment to Loan Agreement and Other Loan Documents, dated as of July 18, 2007 (the “First Amendment”) whereby the Initial Loan amount was increased by Eighteen Million and 00/100 dollars ($18,000,000), collectively making the aggregate principal loan amount Forty-Four Million and 00/100 dollars ($44,000,000) (the “Loan”) and in connection with the First Amendment, Borrower executed that certain Amended and Restated Promissory Note dated as of July 18, 2007, which amended and restated the Original Note in its entirety. The Original Loan Agreement as amended by the First Amendment is hereinafter referred to as the “Loan Agreement”. Capitalized terms not defined herein shall have the meaning ascribed to such terms in the Loan Agreement.

Initial Lender assigned its interests in the Loan, the Loan Agreement, and the other Loan Documents to iStar Tara LLC, a Delaware limited liability company (“Lender”) pursuant to that certain Assignment and Assumption of Note, Mortgage and Other Loan Documents, dated as of March 1, 2009 (the “Assignment”).

Borrower has requested and Lender has agreed to amend Section 2.4 of the Loan Agreement to permit a prepayment of the Loan as specifically set forth herein.

1. Notwithstanding anything to the contrary express or implied set forth in Section 2.4(C)(i) of the Loan Agreement, Lender hereby agrees that so long as no Event of Default exists and provided Borrower repays the Loan in full on or before January 5, 2010, Borrower may prepay the Loan at any time during such period, in whole or in part, and without payment of the Prepayment Premium. Borrower has advised Lender that it intends to prepay the aggregate principal amount of the Loan in accordance with the following payment schedule:

(a) On the first Business Day of July, 2009, a payment in the amount of Five Million and 00/100 Dollars ($5,000,000.00);


(b) On the first Business Day of August, 2009, a payment in the amount of Five Million and 00/100 Dollars ($5,000,000.00);

(c) On the first Business Day of September, 2009, a payment in the amount of Five Million and 00/100 Dollars ($5,000,000.00);

(d) On the first Business Day of October, 2009, a payment in the amount of Five Million and 00/100 Dollars ($5,000,000.00);

(e) On the first Business Day of November, 2009, a payment in the amount of Five Million and 00/100 Dollars ($5,000,000.00);

(f) On the first Business Day of December, 2009, a payment in the amount of Five Million and 00/100 Dollars ($5,000,000.00); and

(g) On or prior to January 5, 2010, the remaining principal balance of the Loan, together with all accrued and unpaid interest and any other amounts that are due under the Loan Agreement.

Lender and Borrower agree and acknowledge that Borrower may prepay the Loan sooner than the schedule provided herein; provided, however, if the Loan is not repaid in full on or before January 5, 2010, any prepayment of the Loan made after January 5, 2010, in part or in whole, shall be subject to the payment of the applicable Prepayment Premium and the other terms, conditions and restrictions as set forth in Section 2.4(C) of the Loan Agreement.

2. To the extent the Loan is not repaid in full on or before January 5, 2010, Lender and Borrower agree that on or before March 1, 2010 (when the Loan is scheduled to start amortizing as set forth in Section 2.3 of the Loan Agreement), Lender shall establish a new amortization schedule to replace the amortization schedule that is currently set forth in Section 2.3 of the Loan Agreement based on the then outstanding principal balance such that the Loan will fully amortize during the remaining term of the Loan commencing on March 1, 2010 through the Maturity Date.

3. In order to induce Lender to execute this Amendment, Borrower and Guarantor represent and warrant as follows:

(a) This Amendment, and any other documents and instruments required to be executed and delivered by Borrower and/or Guarantor in connection herewith, when executed and delivered, will constitute the duly authorized, valid and legally binding obligations of Borrower and Guarantor, as applicable, and will be enforceable in accordance with their respective terms, subject only to bankruptcy and insolvency laws of general applicability and the application of general principles of equity.

 

2


(b) The execution, delivery and performance of this Amendment, the Loan Documents as modified by this Amendment and any other documents or instruments to be executed and delivered by Borrower and Guarantor in connection herewith will not: (i) violate any laws or (ii) conflict with, be inconsistent with, or result in any breach or default of any of the terms, covenants, conditions, or provisions of any indenture, mortgage, deed of trust, corporate charter or bylaws, instrument, document, agreement or contract of any kind to which Borrower or Guarantor is a party or by which Borrower or Guarantor may be bound. Borrower and Guarantor are not in default (beyond applicable grace or cure periods) under any contract or agreement to which each is a party, the effect of which default will materially adversely affect the performance by Borrower or Guarantor of their representative obligations pursuant to and as contemplated by the terms and provisions of this Amendment and the Loan Documents as modified by this Amendment.

(c) The representations and warranties made by Borrower and Guarantor in the Loan Documents, as modified by this Amendment, to which each such person or entity is a party are true, correct, and complete in all material respects as of the date of this Amendment, except to the extent that such representations and warranties specifically relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects on and as of such earlier date.

(d) Neither Borrower nor Guarantor has any defenses, claims, offsets or setoffs with regard to the enforcement of the Loan Documents.

4. Notwithstanding anything contained in this Amendment to the contrary or any prior act of Lender or any procedure established by Lender with regard to the Loan, Borrower acknowledges and agrees that Lender has not heretofore waived any of its rights or remedies under the Loan Documents nor has Lender waived any of the duties or obligations of Borrower thereunder. No waiver by Lender of any covenant or condition under the Loan Documents shall be deemed a subsequent waiver of the same or any other covenant or condition. No covenant, term or condition of the Loan Documents shall be deemed waived by Lender unless in writing.

5. Borrower and Guarantor agree that the Loan Agreement and the other Loan Documents, including without limitation, the Completion, Payment and Performance Guaranty and the Environmental Indemnity Agreement, as amended by this Amendment, remain in full force and effect in accordance with the previously existing terms thereof, as amended by this Amendment, and such documents and instruments are hereby ratified and confirmed.

6. The undersigned, as Guarantor, hereby consents to the amendment of the Loan Documents pursuant to the terms and conditions of this Amendment. Guarantor hereby reaffirms all of the obligations of Guarantor under the Completion, Payment and Performance Guaranty and the Environmental Indemnity Agreement.

7. This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.

8. This Amendment shall be construed in accordance with and governed by the internal laws of the State of New York.

 

3


9. The parties hereto expressly acknowledge and agree that this Amendment shall not be construed as a novation of the Amended Note, Mortgage or any other Loan Document.

10. All of the Mortgaged Property shall remain in all respects subject to the lien, charge and encumbrance of the respective Mortgage, as herein modified, and nothing herein contained and nothing done pursuant hereto, shall affect the lien, charge or encumbrance of the respective Mortgage, as herein modified, or the priority thereof with respect to other liens, charges, encumbrances or conveyances, or release or affect the liability of any part or parties whomsoever, who may now or hereafter be liable under, or on account of, the Loan Documents.

11. The execution and delivery of this Amendment does not constitute a waiver of any default under the Amended Note, Mortgage or any of the other Loan Documents.

12. Time is hereby declared to be of the essence of this Amendment and of every part hereof.

[The Rest of this Page Intentionally Blank]

 

4


Very truly yours,
ALEXION MANUFACTURING LLC, a Delaware limited liability company
By:       ALEXION PHARMACEUTICALS, INC., a Delaware corporation, its sole member
  By:  

/s/    Vikas Sinha

  Name:   Vikas Sinha
  Its:   Senior VP and CFO
ALEXION PHARMACEUTICALS, INC., a
Delaware corporation
  By:  

/s/    Vikas Sinha

  Name:   Vikas Sinha
  Its:   Senior VP and CFO

Agreed to and Accepted as of the 30th day of June, 2009

iSTAR TARA LLC, a Delaware limited liability company

 

By:  

/s/    Cynthia Tucker

Name:   Cynthia Tucker
Its:   Senior Vice President

 

5

-----END PRIVACY-ENHANCED MESSAGE-----